Does BLINATUMOMAB Cause Agranulocytosis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Agranulocytosis have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.1% of all adverse event reports for BLINATUMOMAB.
8
Reports of Agranulocytosis with BLINATUMOMAB
0.1%
of all BLINATUMOMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Agranulocytosis From BLINATUMOMAB?
Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization, and 3 (37.5%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for BLINATUMOMAB.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which BLINATUMOMAB Alternatives Have Lower Agranulocytosis Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA